Zika Virus Clinical Trial
Official title:
A Phase 2, Randomized, Observer-Blind, Placebo-Controlled, Dose Confirmation Study to Evaluate the Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Adults Aged 18 Through 65 Years and Living in Endemic and Non-Endemic Flavivirus Areas
This clinical study will evaluate the safety, tolerability, and reactogenicity of 2 dose levels of messenger RNA (mRNA)-1893 Zika vaccine in comparison to a placebo control in healthy participants who are flavivirus-seronegative and in participants who are flavivirus-seropositive.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04182685 -
Evaluation of Medical Conditions Associated With Zika Virus Infection in Managua, Nicaragua
|
||
Enrolling by invitation |
NCT04398901 -
Neurodevelopmental Outcomes in ZIKV-Exposed Children
|
||
Completed |
NCT02996890 -
Zika-Vaccine Dose Finding Study Regarding Safety, Immunogenicity and Tolerability (V186-001)
|
Phase 1 | |
Completed |
NCT03188731 -
ZIKAlliance Pregnant Women Cohort
|
||
Completed |
NCT03110770 -
VRC 705: A Zika Virus DNA Vaccine in Healthy Adults and Adolescents
|
Phase 2 | |
Completed |
NCT02794181 -
Zika Virus and Related Arbovirus Infections in Deferred Blood Donors (ZVADD)
|
||
Recruiting |
NCT01099852 -
Cohort of Patients Infected by an Arbovirus
|
||
Completed |
NCT03611946 -
Evaluation of the Safety and Immunogenicity of the Live Attenuated Zika Vaccine rZIKV/D4Δ30-713 in Flavivirus-naïve Adults
|
Phase 1 | |
Completed |
NCT04064905 -
Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults
|
Phase 1 | |
Completed |
NCT03106714 -
Study on the Persistence of Zika Virus (ZIKV) in Body Fluids of Patients With ZIKV Infection in Brazil
|
||
Completed |
NCT02979938 -
Understanding Excretion and Infectivity of Zika Virus in Semen During and After Infection
|
||
Recruiting |
NCT03227601 -
Effect of a Posture Adapter for 12 to 24-month Children With Zyka Virus Syndrome
|
N/A | |
Completed |
NCT03393286 -
ZIKAlliance Children Cohort (ZIKAllianceCH)
|
||
Completed |
NCT03425149 -
Randomized, Placebo-controlled, Observer-blinded Phase 1 Safety and Immunogenicity Study of Inactivated Zika Virus Vaccine Candidate in Healthy Adults
|
Phase 1 | |
Recruiting |
NCT05123222 -
Evaluation of Two Zika Viruses for Use in Controlled Human Infection Models (CHIM)
|
Phase 1 | |
Completed |
NCT02733796 -
Persistence of Zika Virus in Semen After Acute Infection
|
||
Completed |
NCT03014089 -
Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects
|
Phase 1 | |
Completed |
NCT03263195 -
Prospective Cohort Study of HIV and Zika in Infants and Pregnancy
|
||
Withdrawn |
NCT03204409 -
ZIKAlliance Natural History Study
|